SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 193 filers reported holding SEATTLE GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $508,000 | -85.2% | 9,492 | -85.7% | 0.02% | -84.5% |
| Q2 2017 | $3,430,000 | +1170.4% | 66,301 | +1194.7% | 0.13% | +1072.7% |
| Q4 2016 | $270,000 | -82.9% | 5,121 | -89.6% | 0.01% | -79.2% |
| Q4 2014 | $1,575,000 | +187.9% | 49,017 | +233.3% | 0.05% | +231.2% |
| Q3 2014 | $547,000 | -56.7% | 14,706 | -55.4% | 0.02% | -52.9% |
| Q2 2014 | $1,263,000 | -60.7% | 33,009 | -59.1% | 0.03% | -64.2% |
| Q4 2013 | $3,217,000 | – | 80,641 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |